The challenges facing drug development are apparent, with costs skyrocketing and the pace of new medicine production slowing. An insightful article delves into the root causes of these issues, pointing to regulations and misaligned incentives as major culprits. But how can we improve the system? The answer may lie in fostering competition through medical tourism, as traditional efforts within the system have fallen short. By reimagining the role of medical tourism and creating hybrid organizations that blend various aspects of medical development, we may finally see meaningful change in the industry. The pharma industry has seen a decline in productivity over the years, with the cost of drug discovery and development soaring. The article examines how these structural shifts have made drug development increasingly challenging and offers insights into potential solutions. Take a deep dive into the complexities of the drug development industry and explore how we can address the underlying issues to drive progress forward.
A Lengthy View of Everything that is Wrong with the Drug Development Industry – Fight Aging!
Leave a comment